• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    4D Pharma Plc ADR (NQ: LBPS )

    N/A UNCHANGED
    Last Price Updated: 9:38 AM EDT, Jun 24, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.610 (1)
    Ask (Size) 1.660 (2)
    Prev. Close 1.650
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq
    From 4D pharma plc
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022
    Upgrades 
    Via Benzinga

    Performance

    More News

    Read More
    Update on Suspension of Trading
    From 4D pharma
    Via Business Wire
    76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    40 Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    67 Biggest Movers From Yesterday
    Via Benzinga
    45 Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
    From 4D pharma plc
    Via Business Wire
    4D pharma to Present at the H.C. Wainwright Global Investment Conference
    From 4D pharma
    Via Business Wire
    4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference
    From 4D pharma
    Via Business Wire
    24 Stocks Moving in Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    55 Biggest Movers From Friday
    Via Benzinga
    38 Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    21 Stocks Moving in Friday's Pre-Market Session
    Via Benzinga
    4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022
    From 4D pharma plc
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer
    Via FinancialNewsMedia
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.